痛泻要方治疗腹泻型肠易激综合征基础与临床研究进展  

Basic and Clinical Research Progress of Tongxie Yaofang(痛泻要方)in The Treatment of Diarrhea Irritable Bowel Syndrome

作　　者：陈利民[1] 陶琦 牛聪慧 熊莉 杨佳芸 谢潇 余轲 CHEN Limin;TAO Qi;NIU Conghui;XIONG Li;YANG Jiayun;XIE Xiao;YU Ke(Macheng people's Hospital,Macheng 438300,Hubei,China)

机构地区：[1]麻城市人民医院,湖北麻城438300

出　　处：《实用中医内科杂志》2023年第7期108-111,共4页Journal of Practical Traditional Chinese Internal Medicine

基　　金：湖北省卫生健康委中医药科研项目(ZY2021M069)。

摘　　要：肠易激综合征(IBS)病因复杂,中医药因其价格低廉、方便快捷等特点,被广泛用于治疗IBS,不仅疗效高,而且不良反应少。腹泻型肠易激综合征(IBS-D)是IBS主要临床类型,痛泻要方(TXYF)是当前IBS-D基础与临床研究最热门的中药处方,但其科学内涵需要深入发掘,通过对近年来TXYF治疗IBS-D基础与临床研究进行总结,为今后TXYF基础与临床深入研究提供借鉴。The etiology of irritable bowel syndrome(IBS)is complex.Traditional Chinese medicine is widely used in the treatment of IBS because of its low price,convenience and rapidity.It not only has high curative effect,but also has few adverse reactions.Diarrhea irritable bowel syndrome(IBS-D)is the main clinical type of IBS.Tongxie Yaofang(痛泻要方,TXYF)is the most popular traditional Chinese medicine prescription in the basic and clinical research of IBS-D,but its scientific connotation needs to be deeply explored.This paper summarizes the basic and clinical research of TXYF in the treatment of IBS-D in recent years,so as to provide reference for the basic and clinical research of TXYF in the future.

关 键 词：痛泻要方 腹泻型肠易激综合征 基础研究 临床研究 进展 

分 类 号：R256.34[医药卫生—中医内科学]